Skip to main content
OpenTrials
Completed

NCT Number: NCT00469157

Refractive Surgery and Optive Compatibility Study

To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

TLC

Fullerton, California, 92831, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women 18 and over
  • Patients undergoing refractive surgery

Exclusion criteria

  • Concurrent ocular conditions or pathology that could affect patient's ability to complete study
  • Concurrent use of topical medications other than study medications
  • Use of systemic medications with ocular drying sequelae:
  • Antihistamines
  • Decongestants
  • Antispasmotics
  • Antidepressants

Treatment and study plan

Optive

Drug

Optive 30ml- (in the eye) Instill one in each eye twice daily starting one week after surgery

Primary outcomes

  1. Assess compatibility

    Time frame: 8 months

Secondary outcomes

  1. comfort

    Time frame: 8 months

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Innovative Medical

Industry

Registry information

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
May 4, 2007
Registry last updated
Apr 17, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.